Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13624
Country/Region: Côte d'Ivoire
Year: 2017
Main Partner: Sante Espoir Vie - Cote d'Ivoire
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 146,215
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 742
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 635
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 1,018
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 4,993
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 1,867
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 3,869
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 41,432
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 801
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 711
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 4,451
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 1,668
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 5,315
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 6,444
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 46,640
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 19,080
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 71
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 123
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 529
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 189
HTS_TST Sum of Test Result disaggregates 2018 5,660
HTS_TST_POS By Test Result: Positive 2018 5,660
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 146
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 237
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 1,093
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 417
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 44
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 565
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 56
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 28
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 118
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 181
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,725
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 898
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 77
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 34
PMTCT_ART Already on ART at beginning of current pregnancy 2018 417
PMTCT_ART New on ART 2018 688
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,105
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 53,058
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,052
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 201
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 815
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 1
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 35
PMTCT_STAT By Age (Numerator): 10-14 2018 145
PMTCT_STAT By Age (Numerator): 15-19 2018 4,730
PMTCT_STAT By Age (Numerator): 20-24 2018 8,709
PMTCT_STAT By Age (Numerator): 25-49 2018 39,447
PMTCT_STAT By Age (Numerator): 50+ 2018 27
PMTCT_STAT By Number of known positives: 20-24 2018 37
PMTCT_STAT By Number of known positives: 25-49 2018 455
PMTCT_STAT By Number of new negative: 10-14 2018 145
PMTCT_STAT By Number of new negative: 15-19 2018 4,717
PMTCT_STAT By Number of new negative: 20-24 2018 8,600
PMTCT_STAT By Number of new negative: 25-49 2018 38,433
PMTCT_STAT By Number of new negative: 50+ 2018 27
PMTCT_STAT By Number of new positives: 15-19 2018 13
PMTCT_STAT By Number of new positives: 20-24 2018 72
PMTCT_STAT By Number of new positives: 25-49 2018 559
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 53,058
PMTCT_STAT_den By Age (Denominator): <15-19 2018 2,745
PMTCT_STAT_den By Age (Denominator): 10-14 2018 96
PMTCT_STAT_den By Age (Denominator): 20-24 2018 5,794
PMTCT_STAT_den By Age (Denominator): 25-49 2018 34,603
PMTCT_STAT_den By Age (Denominator): 50+ 2018 10
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 10,213
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 114
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 74
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 214
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 193
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 124
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 2
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 85
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 19
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 623
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 23
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 745
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 1,410
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,410
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 19
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 623
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 23
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 745
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 172
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 151
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 4,266
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,439
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 6,028
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 6,028
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 34,983
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 594
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 1
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 345
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 248
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 411
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 292
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 19,884
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 14,396
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 455
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 409
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 2,642
TX_TB_den Denominator: By Screen Result: Negative 2018 31,477
TX_TB_den Denominator: By Screen Result: Positive 2018 3,506
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 3,506